Journal article
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma
Authors
Catenacci DVT; Kang Y-K; Uronis HE; Lee K-W; Ng MCH; Enzinger PC; Park SH; Gold PJ; Lacy J; Hochster HS
Journal
ONCOLOGY-NEW YORK, Vol. 37, No. 4, pp. 175–184
Publisher
UBM MEDICA
Publication Date
April 1, 2023
ISSN
0890-9091